Figure 1From: Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study Kaplan-Meier estimates of time to ( second ) medication switch. Figure 1 shows the Kaplan-Meier curves for the rate of (second) medication switch during follow-up for the OLZ-RIS and RIS-OLZ groups.Back to article page